In This Story
Viking Therapeutics (VKTX) is one of several pharma companies racing to break up the weight loss drug duopoly currently held by Ozempic-maker Novo Nordisk (NVO) and Eli Lilly (LLY), th… [+2599 chars]
Sport Racing
An Ozempic rival is 'onto something pretty amazing' with their experimental weight loss drugs, investor says
Viking Therapeutics (VKTX) is one of several pharma companies racing to break up the weight loss drug duopoly currently held by Ozempic-maker Novo Nordisk (NVO) and Eli Lilly (LLY), the producer of Zepbound. Read more...
